Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Open Access
- 1 January 1985
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 75 (1) , 19-25
- https://doi.org/10.1172/jci111673
Abstract
Asialo von Willebrand factor (AS-vWf) binds to and aggregates normal human platelets in the absence of ristocetin. Maximal specific binding of AS-vWf is 1-2 micrograms vWf protein/10(8) platelets. Despite the specificity of the binding, only 60% of the bound AS-vWf can be dissociated after equilibrium has been reached. We investigated the site of binding and the mechanism of aggregation of platelets by AS-vWf by (a) pre-incubating platelets with either of two monoclonal antibodies, one against glycoprotein Ib (GPIb) or a second against the glycoprotein IIb/IIIa complex (GPIIb/IIIa), and (b) varying the concentration of fibrinogen in the medium. The results of our studies indicate that AS-vWf binds initially to GPIb. This binding then results in the exposure of receptors for AS-vWf on GPIIb/IIIa. In the presence of plasma fibrinogen, both AS-vWf and fibrinogen bind to GPIIb/IIIa. In the presence of plasma fibrinogen, 50% more AS-vWf binds to the platelet, and this additional AS-vWf binds almost exclusively to GPIIb/IIIa. Despite this enhanced binding of AS-vWf in the absence of fibrinogen, platelet aggregation is much less than that which occurs in the presence of plasma fibrinogen. Comparative studies of AS-vWf binding to normal platelets and the platelets of patients with Glanzmann's thrombasthenia reveal decreased binding to the thrombasthenic platelets and a marked decrease in the extent of platelet aggregation. These studies indicate that AS-vWf binding to, and ensuing aggregation of, platelets is different from that observed with intact vWf protein when platelets are stimulated with either ristocetin or thrombin. The AS-vWf binds to GPIb which, in turn, makes additional AS-vWf receptors available on GPIIb/IIIa. If plasma fibrinogen is present, it competes with the AS-vWf for binding to GPIIb/IIIa and causes aggregation of platelets. In the presence of plasma fibrinogen, more of the AS-vWf binds to GPIIb/IIIa, but this AS-vWf is much less effective than fibrinogen in supporting platelet aggregation.Keywords
This publication has 23 references indexed in Scilit:
- The factor VIII complex: structure and function.1981
- Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets.1981
- Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease plateletsThrombosis Research, 1980
- HETEROGENEITY OF HUMAN WHOLE-BLOOD PLATELET SUB-POPULATIONS .2. USE OF A SUBHUMAN PRIMATE MODEL TO ANALYZE RELATIONSHIP BETWEEN DENSITY AND PLATELET AGE1978
- Factor VIII and Human Platelet AggregationBritish Journal of Haematology, 1976
- Platelet‐Aggregating Activity in Neuraminidase‐Treated Human Cryoprecipitates: Its Correlation with Factor‐VIII‐Related AntigenBritish Journal of Haematology, 1974
- Protein iodination with solid state lactoperoxidaseBiochemistry, 1974
- Aggregation of Human Platelets by Bovine or Human Factor VIII: Role of Carbohydrate Side ChainsNature, 1973
- Solid state lactoperoxidase: A highly stable enzyme for simple, gentle iodination of proteinsBiochemical and Biophysical Research Communications, 1972
- STUDIES OF PLATELET FUNCTION AND PROTEINS IN 3 PATIENTS WITH GLANZMANNS THROMBASTHENIA1968